Civic Intelligence

Carson Sarcoma Foundation

EIN 46-4728821 • 501(c)3 • Asheville, NC

Profile

Csf raises funds through families/friends touched by ewing's sarcoma. Efforts will expand to include raising funds from private individuals, corporations, and online activities. Csf partners with a wide array of individuals & institutions to complete csf's mission. These could include, but are not limited to, cancer hospitals, cancer research institutions, other cancer foundations, scientists, biologists, oncologists and pathologists. Csf focuses on targeted cancer research. Targeted cancer research seeks to attack cancer cells while leaving normal cells unharmed. Examples of targeted cancer research include immunotherapy & molecular therapy. Csf seeks out promising therapies that can be utilized by patients within 12-24 months. Csf seeks out projects whose goal is to move their research to stage 1 clinical trials within 24 months.

PO Box 2212Asheville, NC 28802

www.carsonsarcomafoundation.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on the latest valid filing.

Source year 2022

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on the latest valid filing.

Source year 2022

Net Margin

7th percentile

-145%

Higher net margin than 7% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2022

Top Officer Pay

84th percentile

$0

Higher top officer pay than 84% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2022

Asset Growth

37th percentile

-12%

Faster asset growth than 37% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2021 to 2022

Revenue Growth

6th percentile

-93%

Faster revenue growth than 6% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2021 to 2022

Balance Sheet
Liabilities / AssetsScore unavailable

Assets

Down

$0

Down $225,871 (-100%) from 2022

Liabilities

-

No earlier filing loaded for comparison.

Net Assets

Down

$0

Down $225,871 (-100%) from 2022

Operations
Liabilities / RevenueScore unavailableNet Margin7th percentile

Revenue

Up

$23,581

Up $2,431 (+11%) from 2022

Expenses

Up

$249,452

Up $197,609 (+381%) from 2022

Net Income

Down

-$225,871

Down $195,178 (-636%) from 2022

Trend Graphs

Balance Sheet Trend

Asset Growth37th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$300K$200K$100K$0Assets 2015: $88,789Net Assets 2015: $88,7892015Assets 2016: $100,551Liabilities 2016: $0Net Assets 2016: $100,5512016Assets 2017: $47,822Net Assets 2017: $47,8222017Assets 2018: $131,812Net Assets 2018: $131,8122018Assets 2019: $101,011Net Assets 2019: $101,0112019Assets 2020: $164,990Net Assets 2020: $164,9902020Assets 2021: $256,564Liabilities 2021: $0Net Assets 2021: $256,5642021Assets 2022: $225,871Net Assets 2022: $225,8712022Assets 2023: $0Net Assets 2023: $02023

Highlighted filing

2023

Assets$0
Liabilities-
Net Assets$0
Open 2023 Filing

Operations Trend

Revenue Growth6th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$400K$200K$0-$200K-$400KRevenue 2015: $129,461Expenses 2015: $40,672Net Income 2015: $88,7892015Revenue 2016: $363,845Expenses 2016: $352,083Net Income 2016: $11,7622016Revenue 2017: $39,743Expenses 2017: $92,472Net Income 2017: -$52,7292017Revenue 2018: $127,558Expenses 2018: $43,568Net Income 2018: $83,9902018Revenue 2019: $41,508Expenses 2019: $72,309Net Income 2019: -$30,8012019Revenue 2020: $127,068Expenses 2020: $101,304Net Income 2020: $25,7642020Revenue 2021: $283,758Expenses 2021: $192,184Net Income 2021: $91,5742021Revenue 2022: $21,150Expenses 2022: $51,843Net Income 2022: -$30,6932022Revenue 2023: $23,581Expenses 2023: $249,452Net Income 2023: -$225,8712023

Highlighted filing

2023

Revenue$23,581
Expenses$249,452
Net Income-$225,871
Open 2023 Filing

Filings

Most recent year

2023 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$0
Liabilities
-
Net assets
$0
Revenue
$23,581
Expenses
$249,452
Net income
-$225,871
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2023Detailed filing. Detailed filing data is available for this year.$0.00$0.00$0.24$2.49$2.26
2022Detailed filing. Detailed filing data is available for this year.$2.26$2.26$0.21$0.52$0.31
2021Detailed filing. Detailed filing data is available for this year.$2.57$0.00$2.57$2.84$1.92$0.92
2020Detailed filing. Detailed filing data is available for this year.$1.65$1.65$1.27$1.01$0.26
2019Detailed filing. Detailed filing data is available for this year.$1.01$1.01$0.42$0.72$0.31
2018Detailed filing. Detailed filing data is available for this year.$1.32$1.32$1.28$0.44$0.84
2017Detailed filing. Detailed filing data is available for this year.$0.48$0.48$0.40$0.92$0.53
2016Detailed filing. Detailed filing data is available for this year.$1.01$0.00$1.01$3.64$3.52$0.12
2015Detailed filing. Detailed filing data is available for this year.$0.89$0.89$1.29$0.41$0.89
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2023 to Dec 31, 2023
Signed
Mar 30, 2025
Return Version
2023v6.0
Gross Receipts
$23,581
Mission and Program Overview

Mission

Csf raises funds through families/friends touched by ewing's sarcoma. Efforts will expand to include raising funds from private individuals, corporations, and online activities. Csf partners with a wide array of individuals & institutions to complete csf's mission. These could include, but are not limited to, cancer hospitals, cancer research institutions, other cancer foundations, scientists, biologists, oncologists and pathologists. Csf focuses on targeted cancer research. Targeted cancer research seeks to attack cancer cells while leaving normal cells unharmed. Examples of targeted cancer research include immunotherapy & molecular therapy. Csf seeks out promising therapies that can be utilized by patients within 12-24 months. Csf seeks out projects whose goal is to move their research to stage 1 clinical trials within 24 months.

Program Services

DescriptionGrantsExpenses
THE MISSION OF THE CARSON SARCOMA FOUNDATION IS TO FUND TARGETED CANCER RESEARCH FOCUSED ON INCREASING SURVIVAL FOR THOSE STRICKEN WITH ORPHAN SARCOMA CANCERS ULTIMATELY LEADING TO A CURE. THE INITIAL FOCUS IS ON EWING'S SARCOMA CANCER.$246,379$246,379
Compensation and Service Providers
Top Officer Pay84th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
RANDY W CARSONDirector-$0--
DR G THOMAS BUDDBoard Member-$0--
ROBERT NOYES-SMITHBoard Member-$0--
Filing and Contact Details

Filer

Filer Name
Carson Sarcoma Foundation
EIN
46-4728821
Phone
4129966643
Address
PO BOX 2212, ASHEVILLE, NC 28802

Signing Officer

Name
Randy W Carson
Title
Director
Phone
4129966643
Signed
2025-03-30
Discuss with paid preparer
Yes

Preparer

Firm
Austin CPA Pc
Address
301 W HAYWOOD ST, ASHEVILLE, NC 28801-3104
Preparer
Joel Chambers
Phone
8287851556
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 10

“Name: fidelity charitable foundation address: 245 summer st mz nm43a boston, ma 02210 cash contribution: 246,379”

Form 990-ez, Part I, Line 20

“PAYPAL ACCOUNT 0”

Form 990-ez, Part III

“Csf raises funds through families/friends touched by ewing's sarcoma. Efforts will expand to include raising funds from private individuals, corporations, and online activities. Csf partners with a wide array of individuals & institutions to complete csf's mission. These could include, but are not limited to, cancer hospitals, cancer research institutions, other cancer foundations, scientists, biologists, oncologists and pathologists. Csf focuses on targeted cancer research. Targeted cancer research seeks to attack cancer cells while leaving normal cells unharmed. Examples of targeted cancer research include immunotherapy & molecular therapy. Csf seeks out promising therapies that can be utilized by patients within 12-24 months. Csf seeks out projects whose goal is to move their research to stage 1 clinical trials within 24 months.”

Form 990-ez, Part III, Line 28

“The mission of the carson sarcoma foundation is to fund targeted cancer research focused on increasing survival for those stricken with orphan sarcoma cancers ultimately leading to a cure. The initial focus is on ewing's sarcoma cancer.”

Raw XML Appendix141 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0RANDY W CARSON
IRS990EZ/BooksInCareOfDetail/PhoneNum08283333448
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt092 MIDDLEMONT AVE
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0ASHEVILLE
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NC
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd028801
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0225871
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt023581
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt0-225871
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt03073
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/FinalReturnInd0X
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0225871
IRS990EZ/Form990TotalAssetsGrp/EOYAmt00
IRS990EZ/GrantsAndSimilarAmountsPaidAmt0246379
IRS990EZ/GrossReceiptsAmt023581
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0225871
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0225871
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt0000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt1000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt2000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0RANDY W CARSON
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1DR G THOMAS BUDD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2ROBERT NOYES-SMITH
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1BOARD MEMBER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2BOARD MEMBER
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0true
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0CSF RAISES FUNDS THROUGH FAMILIES/FRIENDS TOUCHED BY EWING'S SARCOMA. EFFORTS WILL EXPAND TO INCLUDE RAISING FUNDS FROM PRIVATE INDIVIDUALS, CORPORATIONS, AND ONLINE ACTIVITIES. CSF PARTNERS WITH A WIDE ARRAY OF INDIVIDUALS & INSTITUTIONS TO COMPLETE CSF'S MISSION. THESE COULD INCLUDE, BUT ARE NOT LIMITED TO, CANCER HOSPITALS, CANCER RESEARCH INSTITUTIONS, OTHER CANCER FOUNDATIONS, SCIENTISTS, BIOLOGISTS, ONCOLOGISTS AND PATHOLOGISTS. CSF FOCUSES ON TARGETED CANCER RESEARCH. TARGETED CANCER RESEARCH SEEKS TO ATTACK CANCER CELLS WHILE LEAVING NORMAL CELLS UNHARMED. EXAMPLES OF TARGETED CANCER RESEARCH INCLUDE IMMUNOTHERAPY & MOLECULAR THERAPY. CSF SEEKS OUT PROMISING THERAPIES THAT CAN BE UTILIZED BY PATIENTS WITHIN 12-24 MONTHS. CSF SEEKS OUT PROJECTS WHOSE GOAL IS TO MOVE THEIR RESEARCH TO STAGE 1 CLINICAL TRIALS WITHIN 24 MONTHS.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0THE MISSION OF THE CARSON SARCOMA FOUNDATION IS TO FUND TARGETED CANCER RESEARCH FOCUSED ON INCREASING SURVIVAL FOR THOSE STRICKEN WITH ORPHAN SARCOMA CANCERS ULTIMATELY LEADING TO A CURE. THE INITIAL FOCUS IS ON EWING'S SARCOMA CANCER.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt0246379
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt0246379
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SpecialConditionDesc0FINAL
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt0249452
IRS990EZ/TotalProgramServiceExpensesAmt0246379
IRS990EZ/TotalRevenueAmt023581
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0HTTP://WWW.CARSONSARCOMAFOUNDATION.ORG
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt023581
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt021150
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt0283758
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt0127068
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt038061
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0493618
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/InvestmentIncomePYPct00.00000
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct01.00000
IRS990ScheduleA/PublicSupportPY509Pct01.00000
IRS990ScheduleA/PublicSupportTotal509Amt0493618
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt023581
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt021150
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0283758
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0127068
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt038061
IRS990ScheduleA/Total509Grp/TotalAmt0493618
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt023581
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt021150
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0283758
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0127068
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt038061
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0493618
IRS990ScheduleN/AssetsDistributedInd0false
IRS990ScheduleN/BondsOutstandingInd0false
IRS990ScheduleN/DirectorOfSuccessorInd0false
IRS990ScheduleN/EmployeeOfSuccessorInd0false
IRS990ScheduleN/LiabilitiesPaidInd0false
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/AssetsDistriOrExpnssPaidDesc0CASH
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/DistributionDt02023-12-31
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/FairMarketValueOfAssetAmt0246379
IRS990ScheduleN/OwnerOfSuccessorInd0false
IRS990ScheduleN/ReceiveCompensationInd0false
IRS990ScheduleN/RequiredToNotifyAGInd0false
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0NAME: FIDELITY CHARITABLE FOUNDATION ADDRESS: 245 SUMMER ST MZ NM43A BOSTON, MA 02210 CASH CONTRIBUTION: 246,379
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1PAYPAL ACCOUNT 0
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2CSF RAISES FUNDS THROUGH FAMILIES/FRIENDS TOUCHED BY EWING'S SARCOMA. EFFORTS WILL EXPAND TO INCLUDE RAISING FUNDS FROM PRIVATE INDIVIDUALS, CORPORATIONS, AND ONLINE ACTIVITIES. CSF PARTNERS WITH A WIDE ARRAY OF INDIVIDUALS & INSTITUTIONS TO COMPLETE CSF'S MISSION. THESE COULD INCLUDE, BUT ARE NOT LIMITED TO, CANCER HOSPITALS, CANCER RESEARCH INSTITUTIONS, OTHER CANCER FOUNDATIONS, SCIENTISTS, BIOLOGISTS, ONCOLOGISTS AND PATHOLOGISTS. CSF FOCUSES ON TARGETED CANCER RESEARCH. TARGETED CANCER RESEARCH SEEKS TO ATTACK CANCER CELLS WHILE LEAVING NORMAL CELLS UNHARMED. EXAMPLES OF TARGETED CANCER RESEARCH INCLUDE IMMUNOTHERAPY & MOLECULAR THERAPY. CSF SEEKS OUT PROMISING THERAPIES THAT CAN BE UTILIZED BY PATIENTS WITHIN 12-24 MONTHS. CSF SEEKS OUT PROJECTS WHOSE GOAL IS TO MOVE THEIR RESEARCH TO STAGE 1 CLINICAL TRIALS WITHIN 24 MONTHS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3THE MISSION OF THE CARSON SARCOMA FOUNDATION IS TO FUND TARGETED CANCER RESEARCH FOCUSED ON INCREASING SURVIVAL FOR THOSE STRICKEN WITH ORPHAN SARCOMA CANCERS ULTIMATELY LEADING TO A CURE. THE INITIAL FOCUS IS ON EWING'S SARCOMA CANCER.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 10
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART I, LINE 20
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART III
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART III, LINE 28
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0RANDY W CARSON
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum04129966643
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-03-30
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0CARSON SARCOMA FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0CARS
ReturnHeader/Filer/EIN0464728821
ReturnHeader/Filer/PhoneNum04129966643
ReturnHeader/Filer/USAddress/AddressLine1Txt0PO BOX 2212
ReturnHeader/Filer/USAddress/CityNm0ASHEVILLE
ReturnHeader/Filer/USAddress/StateAbbreviationCd0NC
ReturnHeader/Filer/USAddress/ZIPCd028802
ReturnHeader/IRSResponsiblePrtyInfoCurrInd0false
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0463060158
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0AUSTIN CPA PC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0301 W HAYWOOD ST
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0ASHEVILLE
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0NC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0288013104
ReturnHeader/PreparerPersonGrp/PhoneNum08287851556
ReturnHeader/PreparerPersonGrp/PreparationDt02025-03-29
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0JOEL CHAMBERS
ReturnHeader/ReturnTs02025-04-18T15:18:00-04:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02023-01-01
ReturnHeader/TaxPeriodEndDt02023-12-31
ReturnHeader/TaxYr02023

Document Assets

No mirrored PDF or thumbnail assets are attached yet.